For the Inventor, By the Inventor

Enter assignee name

Columbia, MD, United States of America

Acell, Inc.

USPTO Granted Patents = 41

CIPO Patents = 2

EPO Patents = 5

Trademarks = 10

Forward Citations = 1,197

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Clay D Fette (18 out of 31 patents)

Alan R Spievack (15 out of 22 patents)

Rodney W Bosley, Jr (12 out of 24 patents)

4. Abram D Janis (11 out of 17 patents)

5. Robert S Tullius (7 out of 8 patents)

6. Benjamin T Kibalo (6 out of 10 patents)

7. Kimberly Kentner (5 out of 5 patents)

8. Katherine A Stuart (5 out of 5 patents)

9. Thomas W Gilbert (1 out of 9 patents)

10. Stephen Francis Badylak (1 out of 87 patents)

11. Jiayu Tang (1 out of 1 patent)

12. Luai Huleihel (1 out of 2 patents)

13. Nathaniel Remlinger (1 out of 1 patent)

14. Nikhil Niraj Gheewala (1 out of 1 patent)

15. Chandra M Valmikinathan (1 out of 1 patent)

Core Competencies:

Extracellular Matrix

Porous Foams

Tissue Graft Composition

Bioactive Gels

Hemostatic Device

Tissue Regenerative Composition

Variable Density Tissue Graft

Intestinal Disease Treatment

Particulate Tissue Graft

Decellularized Native Tissues

Cardiac Applications

41 patents: Sort by Forward Citations

1. 11992579 - Porous foams derived from extracellular matrix, porous foam ECM medical devices, and methods of use and making thereof (2024-05-28),

2. 11826490 - Extracellular matrix sheet devices with improved mechanical properties and method of making (2023-11-28),

3. 11013829 - Particulate tissue graft with components of differing density and methods of making and using the same (2021-05-25),

4. 11000628 - Particulate tissue graft with components of differing density and methods of making and using the same (2021-05-11),

5. 10898610 - Particulate tissue graft with components of differing density and methods of making and using the same (2021-01-26),

6. 10517994 - Variable density tissue graft composition and methods of making and using the same (2019-12-31),

7. 10092678 - Extracellular matrix for the treatment of intestinal disease and methods thereof (2018-10-09),

8. 9795713 - Methods of manufacturing bioactive gels from extracellular matrix material (2017-10-24),

9. 9764056 - Hemostatic device (2017-09-19),

10. 9579183 - Variable density tissue graft composition and methods of making and using the same (2017-02-28),

11. 9561307 - Particulate tissue graft with components of differing density and methods of making and using the same (2017-02-07),

12. 9480771 - Hemostatic device (2016-11-01),

13. 9474829 - Methods of manufacturing bioactive gels from extracellular matrix material (2016-10-25),

14. 9433701 - Extracellular matrix for the treatment of intestinal disease and methods thereof (2016-09-06),

15. 9404077 - Hemostatic device (2016-08-02),

ACELL, INC. is a leading biotechnology company that focuses on regenerative medicine. With a mission to enhance the body's natural healing process, ACELL develops and manufactures unique medical products for a variety of applications. Their innovative solutions are widely used in wound care, surgical procedures, and tissue reconstruction. ACELL, INC. is dedicated to improving patient outcomes and transforming the field of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

41 Patents

#8 in Columbia, MD

#93 in Maryland

#8,161 in US

#16,215 in the World

Columbia, MD, United States of America

Acell, Inc.

Forward Citations = 1,197

16 inventors:

Clay D Fette (18 out of 31 patents)

Alan R Spievack (15 out of 22 patents)

Rodney W Bosley, Jr (12 out of 24 patents)

4. Abram D Janis (11 out of 17 patents)

5. Robert S Tullius (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…